Selinexor, a selective inhibitor of nuclear export, enhances the anti-tumor activity of olaparib in triple negative breast cancer regardless of BRCA1 mutation status

Selinexor, a selective inhibitor of nuclear export, enhances the anti-tumor activity of olaparib in triple negative breast cancer regardless of BRCA1 mutation status

10.18632/oncotarget.28047

Saved in:
Bibliographic Details
Main Authors: Marijon, Hélène, Gery, Sigal, Chang, Hua, Landesman, Yosef, Shacham, Sharon, Lee, Dhong Hyun, de Gramont, Aimery, Koeffler, Harold Phillip
Other Authors: MEDICINE
Format: Article
Published: Impact Journals LLC 2022
Subjects:
BRCA1
Olaparib
Selinexor
Triple negative breast cancer
XPO1
Online Access:https://scholarbank.nus.edu.sg/handle/10635/233145
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: National University of Singapore
Be the first to leave a comment!
You must be logged in first

Similar Items